FDA Inspection 1274016 — SGS Canada, Inc.

SGS Canada, Inc. — FEI 3005630028

The FDA completed an inspection of SGS Canada, Inc. on May 22, 2025 in Markham. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 22, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Markham (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.